Drug intelligence / Profile preview

juanbi granules

Development stage: Phase 2
Lead developer: Tianjiang Pharmaceutical
Administration: Oral

Overview

Juanbi Granules (蠲痹颗粒) is a Traditional Chinese Medicine (TCM) herbal formulation used to treat "Bi syndrome," a category of conditions in TCM characterized by pain, heaviness, and swelling in the joints and muscles, often corresponding to rheumatoid arthritis, osteoarthritis, or myofascial pain. The formula is designed to "dispel wind, eliminate dampness, and activate blood circulation" to alleviate pain. It typically contains a blend of herbs such as *Notopterygium incisum*, *Angelica pubescens*, and *Gentiana macrophylla*. In clinical settings, it has been evaluated for its efficacy in reducing pain intensity and improving quality of life in patients with dialysis-related myofascial pain.

Brand names: Juanbi Granules
Other names: 蠲痹颗粒Juanbi-tang

Targets

IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on juanbi granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on juanbi granules.